Researchers report on the long-term immune changes in patients with refractory or relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax and rituximab plus bendamustine and rituximab.
Near 52 Week Low Stocks: Check the list of near 52 week low stocks during the day on NSE/BSE. Find and analyse the stocks / shares which have touched near 52 week low on NSE/BSE.
Some results have been hidden because they may be inaccessible to you